Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

Published:2009-04 Issue:4 Volume:73 Page:833-837
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Kaufman Donald S.,Winter Kathryn A.,Shipley William U.,Heney Niall M.,Wallace H. James,Toonkel Leonard M.,Zietman Anthony L.,Tanguay Simon,Sandler Howard M.

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocols 85-12;Tester;Int J Radiat Oncol Biol Phys,1993

2. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer;Tester;J Clin Oncol,1996

3. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03;Shipley;J Clin Oncol,1998

4. The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response

5. RTOG 97-06: initial report of a phase I/II trial of selective bladder-conservation employing TURB, twice-daily accelerated irradiation sensitized with cisplatin followed by adjuvant MCV combination chemotherapy;Hagan;Int J Radiat Oncol Biol Phys,2003

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer;Trends in Molecular Medicine;2024-07

2. Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2023-07

3. Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives;Translational Andrology and Urology;2023-05

4. Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer;Research and Practical Medicine Journal;2023-03-26

5. Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations;Cancers;2023-02-19